There has been debate about the origin of such tumours. Fine & Stout (1956) suggested that extraskeletal osteosarcomas might represent malignant growth of a single component in a teratoma. Chitiyo (1973) listed four possible methods of histogenesis: metaplasia of bladder mucosa epithelium, stromal metaplasia, transfer of osteoblasts via the bloodstream, or the development of osteoblasts from the immature mesenchyme of the Wolfian body, from which the trigone develops. The same author felt there was little evidence for the Wolfian body origin theory. However, Kikuchi et al. (1965) considered that the frequent location of these bladder tumours in the trigone was evidence of an origin from the Wolfian body. Of the 25 previous reports of bladder tumours containing bone or cartilage, 17 were in trigone, bladder neck or near the ureteric orifices and in the present case the lesion also originated in the trigone. Transfer of osteoblasts via the bloodstream seems unlikely as the mean age in the previous cases was 61.5 years with a range 41 to 83 years. Males have been affected in 21 cases and females in 4 cases, with metastatic spread reported in only 5 previous cases.
Pang (1958) reported that the commonest symptom was haematuria, although this did not occur in our patient. The same author felt that in general these tumours were less malignant than undifferentiated sarcomas of the bladder and osteosarcomas of the skeleton. Chitiyo (1973) , however, reported a poor prognosis. Many of the previous cases were diagnosed at post-mortem examination and few underwent surgery. Murat et al. (1975) advised local excision. Jones & Ross (1950) had one patient who survived 6 years after partial cystectomy. All other patients who underwent surgery died within 2 months, many from urinary infection in the pre-antibiotic era. Apart from our patient, no others underwent total cystectomy and it is unfortunate that such rapid local tumour recurrence took place.
No previous cases of osteosarcoma or chondrosarcoma had undergone radiotherapy to the bladder, although sarcomatous changes have been reported following irradiation (Kim et al. 1978 ) with a latent period of up to 40 years. It is possible that irradiation was responsible for the second bladder tumour 27 years later, although the dose (7000 rad) would have been localized to the bladder as far as possible. It is of interest that the patient had a radiation-induced menopause 4 years after the initial bladder tumour. This would suggest that the initial dose of radiation in her pelvis had been insufficient to produce total ovarian ablation.
Clinitest tablets have been used for many years by diabetic patients for monitoring urinary sugar. The tablets are white with green-blue flecks, and each contains copper sulphate (20 mg), citric acid (300 mg), sodium hydroxide (232.5 mg) and sodium carbonate (80 mg). Sugar in the urine reduces the cupric salt to cuprous oxide, resulting in a colour change, and the sodium hydroxide not only provides the strongly alkaline pH required but, through its reaction with water and citric acid, generates the heat necessary for the reaction to take place. Tissue injury after ingestion of these tablets can therefore result from the intense heat of hydration of the concentrated sodium hydroxide as well as by direct corrosive action (Burrington 1975) . We have recently seen a patient who died after accidental ingestion of Clinitest tablets and the purpose of this report is to draw attention to a potentially serious clinical problem which can easily be prevented. However, in order to put this case into perspective, we have compared it with further data on Clinitest ingestion from the London centre of the UK National Poisons Information Service (NPIS). A 77-year-old widow who lived alone was initially seen at an outpatient clinic in March 1982 complaining of weight loss, thirst, and forgetfulness; she was found to have 2% glycosuria and fasting hyperglycaemia and maturity-onset diabetes mellitus was diagnosed. In the past she had undergone bilateral cataract surgery and was partially deaf. She remained generally well taking glibenclamide 2.5 mg daily and on another clinic visit was given Clinitest tablets with which to test her own urine. The day after they were supplied, she was brought to the Casualty Department having swallowed two of the tablets three hours previously with a cup of tea; she thought she had taken the tablets through absent-mindedness. There were no immediate ill effects and physical examination showed no evidence of oropharyngeal ulceration; she was given cold milk to drink and allowed home the following day. She presented again two weeks later with increasing dysphagia and could only swallow fluids. At upper gastrointestinal endoscopy a tight oesophageal stricture was seen at 19 cm from the incisor teeth. The patient was able to drink fluids during the 48 hours following endoscopy, but on the third hospital day she had a massive haematemesis and died. At postmortem, an ovoid ulcer 5 cm in length was found in the upper oesophagus opposite the arch of the aorta. This had penetrated deeply and perforated the aortic wall to form an oesophago-aortic fistula. There was no evidence of pharyngeal or gastric ulceration.
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NPIS cases
During the three years 1980-1982, the NPIS received twelve enquiries concerning Clinitest ingestion which are sufficiently complete for the short-term outcome to be clear. These cases are summarized in Table 1 . There were no fatalities, despite the fact that one patient may have taken as many as 36 tablets, suffering dysphagia, abdominal pain and diarrhoea; this patient was treated with a plentiful oral fluid intake. Another patient had a tablet lodged in the oesophagus and an ulcer was seen on endoscopy. Oral burns, dysphagia, vomiting, and a haematemesis occurred in the other symptomatic patients, and two had no symptoms. It is possible that many other cases occur where the patient is asymptomatic, since a poisons information service is more likely to be consulted when a patient presents with symptoms.
Discussion
Accidental ingestion of Clinitest by adults is, unlike the ingestion of other strong alkalis, more common than suicidal ingestion. It can occur when the tablets are mistaken for an oral medication by a patient with dementia, or a diabetic with impaired vision. The swallowed tablet mixes with saliva and usually sticks in the upper third of the oesophagus because of thermal coagulation of the mucosa. This results in ulceration and characteristically rapid (1-3 weeks) stricture formation (Mallory & Schaefer 1977) . In our case ulceration progressed to an oesophago-aortic fistula over the three weeks following ingestion and this, to our knowledge, is the first reported death following accidental Clinitest ingestion. Fibreoptic endoscopy is the preferred method of evaluating a patient after ingestion of a corrosive agent like Clinitest, and the examination should proceed only to the proximal margin of injury to avoid further trauma to the compromised tissue (Lowe et al. 1979) . Cold milk has been proposed as the antidote of choice as milk protein forms a coagulum that envelops the tablet and insulates against further thermal and caustic damage (Burrington 1975) . However, coating the tablet is unlikely to help if it is already lodged. The most important immediate measure is to get the patient to swallow 3 or 4 glasses of milk or water, whichever is more readily available.
Increased awareness by physicians and patients of the caustic properties of Clinitest is needed in order to minimize the chance of accidental ingestion. Alternative methods of urine testing should be prescribed for those patients who would be likely to ingest Clinitest accidentallypatients with visual or language problems, demented or alcoholic patients, and those already taking many tablets. Changes in the size and shape of Clinitest tablets to make them less like many oral medications would also be a helpful preventive measure, and the label should contain instructions on what to do if a tablet is swallowed. Assisted ventilation may be necessary in acute severe asthma when medical treatment fails (Jones 1971). Prolonged ventilation is unusual (Webb et al. 1979 ) and we describe a patient with severe asthma in whom this was required. We believe this was related to a coincident Guillain-Barre-Strohl (GBS) syndrome. Prolonged ventilation in asthmatics may not always be the result of airways obstruction and other causes should be sought.
Case report
A 45-year-old man presented with severe bronchospasm following a flu-like illness. He had a previous history of asthma controlled with regular inhalation of Ventolin and Becotide, and of schizophrenia for which he had not received treatment for the preceding 5 years. On admission he could barely speak and was noted to have a pulse rate of 1 10/min, pulsus paradoxus of 20 mmHg and a peak expiratory flow rate (PEFR) of 80 1/min. Neurological examination was entirely normal. Treatment was commenced on 60% oxygen, nebulized salbutamol 1 ml in 3 ml saline three-hourly, intravenous aminophylline 250 mg six-hourly and hydrocortisone 200 mg six-hourly, producing an initial improvement with a PEFR of 100 1/min and a pulse of 100 I/min over the following 12 hours. Subsequently, the patient deteriorated with an unrecordable PEFR and a pulse of 140/min. The blood gases on 60% oxygen were Paco2 6.9 kPa (52 mmHg), Pao2 13.6 kPa (120 mmHg) and pH 7.15. The patient was transferred to the intensive care unit and artificially ventilated with intermittent positive pressure ventilation. Over the next 3 days he improved with continuous intravenous hydrocortisone, aminophylline and nebulized salbutamol. Intravenous feeding was commenced on day 4. After 6 days an attempt at weaning from the ventilator was unsuccessful. The patient developed a Paco2 of 8.2 kPa (61 mmHg). On the tenth day further weaning from the ventilator was attempted and again failed. Neurological assessment at this time 1Accepted 17 May 1984
